ePrivacy and GPDR Cookie Consent by TermsFeed Generator

Detail of the clinical trial

Title of the trial A Randomized, Open-label Study of Ponatinib Versus Nilotinib in Patients with Chronic Myeloid Leukemia in Chronic Phase Following Resistance to Imatinib
EudraCT number 2015-001318-92
Protocol number AP24534-15-303
Sponsor ARIAD Pharmaceuticals, Inc.,26 Landsdowne Street,Cambridge,MA 02139
Indications Hemato-oncology
Diagnosis Chronic Myeloid Leukemia
Population in clinical trial Adults (18-65 years)
Elderly ( > 65 years)
Year of receiving the request to Institute (SÚKL) 2015
Date of approval by Institute (SÚKL) 15.12.2015
Date of approval by EC 18.1.2016
Date of initiation CT in ČR 1.11.2016
Date of ending CT in ČR 7.4.2020
Sites FN Ostrava, Klinika hematoonkologie, 17. listopadu 1790, 708 52 Ostrava - Poruba
FN Hradec Králové, IV. interní hematologická klinika, Sokolská 581, Hradec Králové 500 05
Fakultní nemocnice Olomouc,,I.P. Pavlova 6,Olomouc,775 20

‹‹ Back to list